In this way, DANCR overexpression in bladder cancer leads to a pathological activation of pro-lymphangiogenic VEGF-C signaling, thereby promoting tumor lymphangiogenesis and LN metastasis. The gene discussed is VEGFC; the disease is urinary bladder cancer.